NMLSF closed today higher at $0.05, an increase of 1.3569% from yesterday's close, completing a monthly increase of 40.8571% or $0.01. Over the past 12 months, NMLSF stock lost -39.6573%.
NMLSF is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0071%, based on the last three reports.
Restart Life Sciences Corp. has completed 5 stock splits, with the recent split occurring on Jan 24, 2025.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).